← Open Payments lookup

FELIPE NOVOA: Open Payments

NPI 1770905283 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$30,121 in 89 payments from 14 companies in 2025. Trend: 2023 $19,483 · 2024 $40,085 · 2025 $30,121

Speaker / faculty: $17,280Travel & lodging: $8,578Food & beverage: $2,756Consulting: $1,508
CompanyPaymentsAmount
GlaxoSmithKline, LLC.60$25,443
E.R. Squibb & Sons, L.L.C.6$2,506
Takeda Pharmaceuticals U.S.A., Inc.1$1,403
Novartis Pharmaceuticals Corporation2$228
SOBI, INC3$93
Celgene Corporation4$89
GENZYME CORPORATION2$83
Geron Corporation3$61
Blueprint Medicines Corporation2$57
Stemline Therapeutics Inc.2$51

Products named: OJJAARA, REBLOZYL, SCEMBLIX, AYVAKIT, RYTELO, Doptelet, ELZONRIS, clonoSEQ.

Industry payments across FL — which companies pay providers there.